CAS 1422144-42-0

Formule : C30H35N3O9S2

InChI : InChI=1S/C28H27N3O3.2CH4O3S/c1-18-3-10-25(19(2)13-18)28(33)34-17-20-4-6-21(7-5-20)26(15-29)27(32)31-24-9-8-23-16-30-12-11-22(23)14-24;2*1-5(2,3)4/h3-14,16,26H,15,17,29H2,1-2H3,(H,31,32);2*1H3,(H,2,3,4)/t26-;;/m1../s1

Code InChI : QQDRLKRHJOAQDC-FBHGDYMESA-N

SMILES : CC1=CC(=C(C=C1)C(=O)OCC2=CC=C(C=C2)[C@@H](CN)C(=O)NC3=CC4=C(C=C3)C=NC=C4)C.CS(=O)(=O)O.CS(=O)(=O)O

Benzoic acid, 2,4-dimethyl-, [4-[(1S)-1-(aminomethyl)-2-(6-isoquinolinylamino)-2-oxoethyl]phenyl]methyl ester, methanesulfonate (1:2)

CAS : 1422144-42-0

Formule : C₃₀H₃₅N₃O₉S₂

Degré de pureté : 97%

Couleur et forme : Solid

Masse moléculaire : 645.7436

Ref: IN-DA001HZD

Netarsudil Dimesylate

CAS : 1422144-42-0

Formule : C₂₈H₂₇N₃O₃·2CH₄O₃S

Couleur et forme : White To Off-White Solid

Masse moléculaire : 453.54 2*96.10

Ref: 4Z-N-141001

Netarsudil mesylate

CAS : 1422144-42-0

Netarsudil mesylate

Formule : C₃₀H₃₅N₃O₉S₂

Degré de pureté : ≥98%

Masse moléculaire : 645.74

Ref: 54-BUP13977

Netarsudil mesylate

CAS : 1422144-42-0

Netarsudil mesylate (AR-13324 mesylate) is a Rho-related protein kinase inhibitor used to study glaucoma and hypertension.

Formule : C₃₀H₃₅N₃O₉S₂

Degré de pureté : 99.7%

Couleur et forme : Solid

Masse moléculaire : 645.74

Ref: TM-T10358L2

Netarsudil Mesylate

CAS : 1422144-42-0

(S)-4-(3-Amino-1-(isoquinolin-6-ylamino)-1-oxopropan-2-yl)benzyl 2,4-dimethylbenzoate dimethanesulfonate

Formule : C₃₀H₃₅N₃O₉S₂

Degré de pureté : 98%

Masse moléculaire : 645.74

Ref: IN-DG01194637

Netarsudil mesylate

CAS : 1422144-42-0

Formule : C₃₀H₃₅N₃O₉S₂

Masse moléculaire : 645.7

Ref: BE-RMCN066001

AR-​13324 mesylate

Produit contrôlé

CAS : 1422144-42-0

Formule : C₂₈H₂₇N₃O₃·2CH₄O₃S

Couleur et forme : Neat

Masse moléculaire : 645.744

Ref: TR-A253320

Netarsudil Dimesylate

CAS : 1422144-42-0

Formule : C₂₈H₂₇N₃O₃(CH₄O₃S)

Masse moléculaire : 453.54 : 2(96.1)

Ref: ST-EA-CP-N39004

AR-13324 mesylate

CAS : 1422144-42-0

AR-13324 mesylate is a pharmaceutical compound, which is a selective Rho kinase inhibitor derived from chemical synthesis with a specific mode of action targeting the modulation of aqueous humor outflow in the eye. Structurally, it is designed to inhibit the Rho-associated protein kinase (ROCK) pathway, which plays a crucial role in controlling various cellular functions including contraction, motility, proliferation, and apoptosis, specifically affecting the trabecular meshwork and uveoscleral pathway in ocular tissues.

Formule : C₂₉H₃₁N₃O₆S

Degré de pureté : Min. 95%

Masse moléculaire : 549.64 g/mol

Ref: 3D-XGC14442